SARS-CoV-2 Spike-E-M Mosaic protein is a recombinant antigen manufactured in E. coli with greater than 95% purity, and containing the Spike (S), Envelope (E) and Membrane (M) immunodominant regions. SARS-CoV-2, previously known as the 2019 Novel Coronavirus (2019-nCoV), causes the pandemic COVID-19 disease.
Human Coronavirus 229E Nucleoprotein is a recombinant protein containing 359 amino acids derived from the nucleocapsid sequence, with a C-terminal 6xHis tag. It is manufactured in E. coli with greater than 95% purity.
Human Coronavirus NL63 Nucleoprotein is a recombinant protein containing the nucleocapsid C-terminal region (130 amino acids), cloned and expressed in E. coli, and purified by affinity chromatography (nickel column) with greater than 95% purity.
The most comprehensive, high-performance protein biomarker panel available for inflammation studies.
Together with our Neuro Exploratory panel, this provides the most comprehensive, high-performance protein biomarker solution available for neurological disease studies.
One tube, one-touch – fully automated urine workflow
Gyrolab® Bioaffy™ 200, the most versatile disc in the Bioaffy range, with 112 data points and 200 nL sample volume this disc fits many different applications.
The NovaFluor Conjugation Kit provides a simple workflow to conjugate each of our 3 NovaBlue and 3 NovaYellow labels to your antibodies with just 3 pipetting steps.
Twist Biopharma, a division of Twist Bioscience, provides services to help accelerate the way our partners discover and optimize antibody therapeutics with our unique DNA writing technology. Twist constructs proprietary antibody libraries precisely designed to match sequences that occur in the human body giving our partners an integral and unbiased resource for antibody therapeutic discovery and optimization.
Twist Biopharma, a division of Twist Bioscience, provides services to help accelerate the way our partners discover and optimize antibody therapeutics with our unique DNA writing technology. Twist constructs proprietary antibody libraries precisely designed to match sequences that occur in the human body giving our partners an integral and unbiased resource for antibody therapeutic discovery and optimization.
SARS-CoV-2 Nucleocapsid, clone 502 Monoclonal Antibody (matched pair with clone 504)
SARS-CoV-2 Nucleocapsid, clone 503 Monoclonal Antibody (matched pair with clone 504)
2019-nCoV Nucleocapsid Recombinant Antigen,full length (Ag-6)
COVID-19, MERS & SARS-CoV, Nucleoprotein Antibody, 1057
COVID-19, MERS & SARS-CoV, Nucleoprotein Antibody, 1058
SARS-CoV-2 Nucleocapsid, clone 504 Monoclonal Antibody (matched pair with clone 502 or 503)
SARS-CoV-2 Nucleocapsid, clone 2A1 Monoclonal Antibody (matched pair with clone 2C1)
SARS-CoV-2 Nucleocapsid, clone 2C1 Monoclonal Antibody (matched pair with clone 2A1)
SARS-CoV-2 Nucleocapsid, clone 4D8 Monoclonal Antibody (matched pair with clone 5B7)
SARS-CoV-2 Nucleocapsid, clone 5B7 Monoclonal Antibody (matched pair with clone 4D8)
SARS-CoV-2 Nucleocapsid,clone 7B3 Monoclonal Antibody (matched pair with clone 5D4)
SARS-CoV-2 Nucleoprotein (aa 1-419) Recombinant Antigen, 613
SARS-CoV-2 Spike (RBD, aa 331-524) Recombinant Antigen
SARS-CoV-2 Spike Protein S1 (aa 1-674) Recombinant Antigen
HistologiX is a leading GLP/GCP accredited Contract Research Organisation based in the UK specialising in Histology, Immunohistochemistry (IHC) and Digital Pathology services. HistologiX works with a broad range of clients from big pharma to small and medium biotech companies worldwide. Our team of scientists have in excess of 120 years combined experience and a customer retention rate of 80%.
